Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent.
Bundesrat votes in favour of CanG, with law set to come in on 1 April.
The pilot in canton Zurich will include up to 7,500 participants and is the first to include a randomised control trial as part of the research.
Insiders suggest the move may be a political ploy to put pressure on the bill's opponents.
Researchers found no short-term increase in health service use or frequency of psychotic disorders.
We asked experts in the European cannabis sector about their predictions for 2024.
Global sales of adult-use cannabis are projected to double worldwide by 2027.
The country's first harm-reduction training sessions took place in November.
The number of traffic fatalities either remained stable or decreased in the three years following legalisation.
Five years on the country has seen ‘major societal benefits’ but the public health effects remain a 'mixed picture'.